Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. CancerLinQ Suite
BrandsCancerLinQ Suite

How AI describes CancerLinQ Suite

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

CancerLinQ Suite logoCancerLinQ Suitecancerlinq.org

CancerLinQ is a health technology company that uses real-world data to improve cancer care quality and outcomes. It provides insights for oncologists, researchers, and payers by analyzing data from over 9 million patients across 100+ cancer organizations.

Parse Score

25.5

#9 of 35 in Clinical Trial Feasibility Software

Strength2
Reach21
Authority0

Work at CancerLinQ Suite?

Claim this profile for the full report: every prompt where CancerLinQ Suite appears, who is gaining, and what AI says about you. Claiming is free and unlocks your brand’s ambient view. Monitoring a market is the paid layer on top.

Verified with a work email.

Track this weekly.

Monitor CancerLinQ Suite

Sources

concertai.com shapes more of what AI says about CancerLinQ Suite than any other source, at 100% of its citations.

AI questions where CancerLinQ Suite appears

Always know where you stand in AI

Start monitoring CancerLinQ Suite

The market map

Clinical Trial Feasibility Software →
1%2%5%10%20%50%Category leadersSpecialistsIn the mixLong tailNamed in more AI answers →Appears earlier in the answer →SASDeep 6 AICertaraBerry ConsultantsVerana HealthIQVIATriNetXTempusCytelBEK HealthInovalonEpicinterAdaptFlatiron HealthCancerLinQ Suite

Where AI ranks CancerLinQ Suite

Clinical Trial Feasibility Software#9
Prompt
Prompt visibility
We need to improve patient recruitment. What software helps us analyze EMR data to find eligible candidates for oncology trials?3.8